The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1264
ISSUE 1264
July 2, 2007
Issue 1264
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Arformoterol (Brovana) for COPD
July 2, 2007 (Issue: 1264)
Arformoterol tartrate (Brovana - Sepracor), a singleisomer, long-acting beta2-agonist, has been approved by the FDA as an inhalation solution for nebulization for treatment of bronchoconstriction pulmonary disease (COPD). Arformoterol is the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.